BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18957060)

  • 1. Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples.
    Yamada Y; Arao T; Gotoda T; Taniguchi H; Oda I; Shirao K; Shimada Y; Hamaguchi T; Kato K; Hamano T; Koizumi F; Tamura T; Saito D; Shimoda T; Saka M; Fukagawa T; Katai H; Sano T; Sasako M; Nishio K
    Cancer Sci; 2008 Nov; 99(11):2193-9. PubMed ID: 18957060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
    Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
    J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of malignant and benign gastric biopsy specimens by mRNA expression profile and multivariate statistical methods.
    Galamb O; Sipos F; Molnar B; Szoke D; Spisak S; Tulassay Z
    Cytometry B Clin Cytom; 2007 Sep; 72(5):299-309. PubMed ID: 17366642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
    Sugita H; Iida S; Inokuchi M; Kato K; Ishiguro M; Ishikawa T; Takagi Y; Enjoji M; Yamada H; Uetake H; Kojima K; Sugihara K
    Oncol Rep; 2011 Feb; 25(2):513-8. PubMed ID: 21152877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profile predicts patient survival of gastric cancer after surgical resection.
    Chen CN; Lin JJ; Chen JJ; Lee PH; Yang CY; Kuo ML; Chang KJ; Hsieh FJ
    J Clin Oncol; 2005 Oct; 23(29):7286-95. PubMed ID: 16145069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer.
    Takeno A; Takemasa I; Seno S; Yamasaki M; Motoori M; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Nishida T; Okayama T; Matsubara K; Takenaka Y; Matsuda H; Monden M; Mori M; Doki Y
    Ann Surg Oncol; 2010 Apr; 17(4):1033-42. PubMed ID: 20012501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profile towards the prediction of patient survival of gastric cancer.
    Xu ZY; Chen JS; Shu YQ
    Biomed Pharmacother; 2010 Feb; 64(2):133-9. PubMed ID: 20005068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
    Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
    Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
    Le Page C; Ouellet V; Quinn MC; Tonin PN; Provencher DM; Mes-Masson AM
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):913-20. PubMed ID: 18398031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of tumor size in T3 gastric cancer.
    Liu X; Xu Y; Long Z; Zhu H; Wang Y
    Ann Surg Oncol; 2009 Jul; 16(7):1875-82. PubMed ID: 19373514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of ApoE expression in human gastric cancer.
    Sakashita K; Tanaka F; Zhang X; Mimori K; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
    Oncol Rep; 2008 Dec; 20(6):1313-9. PubMed ID: 19020708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients.
    Tanaka K; Mohri Y; Nishioka J; Kobayashi M; Ohi M; Miki C; Tonouchi H; Nobori T; Kusunoki M
    J Surg Oncol; 2009 Apr; 99(5):307-10. PubMed ID: 19170129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
    Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
    Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
    Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
    Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
    Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of doxorubicin sensitivity in gastric cancers based on a set of novel markers.
    Liu H; Li N; Yao L; Jiang L; Bao G; Li J; Ma Q; Liu Z
    Oncol Rep; 2008 Oct; 20(4):963-9. PubMed ID: 18813841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients.
    Li W; Yu CP; Xia JT; Zhang L; Weng GX; Zheng HQ; Kong QL; Hu LJ; Zeng MS; Zeng YX; Li M; Li J; Song LB
    Clin Cancer Res; 2009 Feb; 15(4):1393-9. PubMed ID: 19228740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.